Igor F. Palacios2014-08-08 Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Igor F. Palacios2014-08-08 Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School
Evaluation and Management of Asymptomatic Aortic Stenosis
Augusto Pichard2014-08-08 Director Innovation and Structural Heart Disease, Vice Chair, Medstar Heart Institute, Medstar Washington Hospital Center. Professor of Medicine (Cardiology),Georgetown University Medical School.Washington, DC
Thromboprophylaxis with antiplatelet agents in patients with mechanical aortic valves
Raúl GarcÃa-Rinaldo2014-08-08 MD, PhD, FACS Ponce School of Medicine, Ponce, PRMayaguez Medical Center, Mayaguez, PR
Hay Lugar Aun Para los Inhibidores GPIIbIIIa?
Pedro Ureña Velásquez2014-08-08 FACC FSCAI FACCPDirector Medicina Cardiovascular Asociada
Denervación de la Arteria Renal en la Hipertensión Arterial Resistente
DarÃo Echeverri2014-08-08 M.D., F.A.C.C.Servicio de Hemodinamia e Intervencionismo CardiovascularFundación CardioInfantil – Instituto de CardiologíaBogotá – Colombia
Below the Knee Interventions and Angiosome Concept
Luis A Guzman2014-08-08 Director, Cardiovascular Cath LabUniversity of Florida-Jacksonville
LAA closure: Available Technology and Clinical Data
Gabriel Maluenda2014-08-08 MD, FACCHospital San Borja Arriaran/Universidad de ChileClínica Alemana, Santiago, Chile
Implante Transcatéter Valvular Aórtico (TAVI): Podremos Ampliar las Indicaciones?
José Mangione2014-08-08
Manejo Endovascular de los Síndromes Agudos de la aorta torácica
Jorge Mayol2014-08-08 Servicio de Cardiología Intervencionista Centro Cardiológico Americano Montevideo – Uruguay
TAVI: Present and Future Perspective
Igor F. Palacios2014-08-08 Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School
- 1
- 2